These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37665236)

  • 21. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
    Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.
    Mann PA; McNicholas PM; Chau AS; Patel R; Mendrick C; Ullmann AJ; Cornely OA; Patino H; Black TA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5026-34. PubMed ID: 19786600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
    Shokri H; Sharifzadeh A
    J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and susceptibility testing of oral candidiasis in advanced cancer patients.
    Monsen RE; Kristoffersen AK; Gay CL; Herlofson BB; Fjeld KG; Hove LH; Nordgarden H; Tollisen A; Lerdal A; Enersen M
    BMC Oral Health; 2023 Apr; 23(1):223. PubMed ID: 37072843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients.
    Menon T; Umamaheswari K; Kumarasamy N; Solomon S; Thyagarajan SP
    Acta Trop; 2001 Oct; 80(2):151-4. PubMed ID: 11600094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India.
    Lattif AA; Mukhopadhyay G; Banerjee U; Goswami R; Prasad R
    J Microbiol Immunol Infect; 2011 Jun; 44(3):166-71. PubMed ID: 21524609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomembranous candidiasis in HIV/AIDS patients in Cali, Colombia.
    Castro LÁ; Álvarez MI; Martínez E
    Mycopathologia; 2013 Feb; 175(1-2):91-8. PubMed ID: 23086383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    Break TJ; Desai JV; Natarajan M; Ferre EMN; Henderson C; Zelazny AM; Siebenlist U; Hoekstra WJ; Schotzinger RJ; Garvey EP; Lionakis MS
    J Antimicrob Chemother; 2018 Jan; 73(1):151-155. PubMed ID: 29040636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.
    Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM
    BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.
    Ghaddar N; Anastasiadis E; Halimeh R; Ghaddar A; Dhar R; AlFouzan W; Yusef H; El Chaar M
    BMC Infect Dis; 2020 Jan; 20(1):32. PubMed ID: 31931738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vulvovaginal candidiasis in Iranian women: Molecular identification and antifungal susceptibility pattern.
    Khaksar Baniasadi A; Ayatollahi Mosavi SA; Sharifi I; Bamorovat M; Salari S; Ahmadi A; Amanizadeh A; Agha Kuchak Afshari S
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3292-3303. PubMed ID: 36184563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon.
    Ambe NF; Longdoh NA; Tebid P; Bobga TP; Nkfusai CN; Ngwa SB; Nsai FS; Cumber SN
    Pan Afr Med J; 2020; 36():23. PubMed ID: 32774600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal.
    Khadka S; Sherchand JB; Pokhrel BM; Parajuli K; Mishra SK; Sharma S; Shah N; Kattel HP; Dhital S; Khatiwada S; Parajuli N; Pradhan M; Rijal BP
    BMC Res Notes; 2017 Jun; 10(1):218. PubMed ID: 28646915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fungal profile and antifungal susceptibility pattern in patients with oral candidiasis.
    Sav H; Altinbas R; Dursun ZB
    Infez Med; 2020 Sep; 28(3):392-396. PubMed ID: 32920575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
    Chryssanthou E; Torssander J; Petrini B
    Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.